Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Philips Expects Recall Settlements This Year: Report

Koninklijke Philips NV (NYSE: PHG) intends to negotiate settlements related to its global recall of respiratory equipment this year.
byAkanksha Bakshi
March 30, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Koninklijke Philips NV (NYSE:PHG) intends to negotiate settlements related to its global recall of respiratory equipment this year.
  • “I think we can at least reach a settlement on economic damages this year,” Reuters quoted CEO Roy Jakobs from an interview with the Dutch financial daily FD.
  • Related: Philips Recalls Some Masks Used With Respiratory Devices Over Potential Injury Risk
  • According to the report, Jakobs added that he “hopes and expects” to settle with the U.S. FDA this year.
  • A settlement with patients who claim the use of the recalled machines made them sick probably will take longer, Jakobs added.
  • Concerns of hefty litigation bills have since reduced Philips’ market value by 70%, added the report.
  • Price Action: PHG shares are trading higher by 6.22% at $17.94 premarket on Thursday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Theriva Biologics Announces Presentation At ESMO Congress 2023 Featuring Survival Outcomes In Phase 1 Study Evaluating VCN-01 In Combination With Durvalumab In Patients With Recurrent/Metastatic Squamous Cell Carcinoma Of The Head And Neck

By Benzinga Newsdesk
October 16, 8:31 AM
-Results from investigator-sponsored study in collaboration with the Institut Catala d'Oncologia (ICO) show enhanced patient survival, correlating with VCN-01 induced upregulation of PD(L)-1- -Key Opinion Leader

TOVX